AG
APYX icon

Algert Global’s Apyx Medical APYX Stock Holding History

Algert Global’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,470
Closed -$49.5K – 1125
2023
Q3 		$49.5K Buy
+15,470
New +$72.1K ﹤0.01% 1070
2016
Q4 		– Sell
-12,570
Closed -$65K – 329
2016
Q3 		$65K Buy
+12,570
New +$40.8K 0.02% 358

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Algert Global's APYX Position: Q4 2023 in Review

Algert Global sold out of Apyx Medical (APYX) in Q4 2023, closing a stake of 15,470 shares — an estimated $49.5K sold.

Algert Global first reported a position in APYX in Q3 2016 and held it in 2 quarters. The position peaked at $65K in Q3 2016. 62 funds tracked by Wall St. Rank hold APYX as of Q4 2023.

  • Algert Global reported no remaining Apyx Medical position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 15,470 Apyx Medical shares in Q4 2023, an estimated $49.5K.
  • Algert Global first reported a position in Apyx Medical in Q3 2016 and held it in 2 quarters.
  • Algert Global's Apyx Medical position peaked at $65K in Q3 2016.
  • 62 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.